The program will be updated continuously with more information.
September 20 |
|
| 11:00-18:30 | |
| 11:00-12:30 | Registration and lunch |
| 12:30-12:35 | Welcome address Richard Rosenquist Brandell, Karolinska Institutet, Sweden |
| 12:35-12:45 | Opening remarks Annika Östman Wernerson, president of Karolinska Institutet, Sweden |
| 12:45-13:00 | Opening speech Jakob Forssmed, Minister for Social Affairs and Public Health, Swedish Government |
| 13:00-13:30 | Keynote address New avenues in precision diagnostics Olli Kallioniemi, SciLifeLab, Karolinska Institutet, Sweden |
| Session 1: Precision Diagnostics in Rare Diseases Chairs: Anna Lindstrand |
|
| 13:30-13:55 | Novel treatment concepts in neuromuscular diseases Jerry Mendell, Nationwide Children's Hospital, USA |
| 13:55-14:20 | Precision therapy in cystic fibrosis Jane Davies, National Heart & Lung Institute, UK |
| 14:20-14:45 | Implementing precision medicine in inherited metabolic diseases Anna Wedell, Karolinska Institutet, Sweden |
| 14:45-15:10 | Panel discussion |
| 15:10-15:40 | Coffee break |
| Session 2: Precision Hematology Chairs: Thoas Fioretos, Eva Hellström-Lindberg |
|
| 15:40-16:05 | Unraveling normal and malignant hematopoietic stem and progenitor cell biology Sten Eirik Jacobsen, Karolinska Institutet, Sweden |
| 16:05-16:30 | From discovery to implementation of precision diagnostics in myeloid malignancies Elli Papaemmanouil, Memorial Sloan Kettering Cancer Center, USA |
| 16:30-16:55 | Genomic profiling for clinical decision-making in lymphoid neoplasms Laurence De Leval, Lausanne University Hospital, Switzerland |
| 16:55-17:20 | Panel discussion |
| 17:20-17:40 | Break |
| Precision Medicine in Action – Best Practice Examples Chair: Kostas Stamatopoulos |
|
| 17:40-18:10 | Implementing genomic sequencing for diagnostics and MRD monitoring Eric Duncavage, Washington University in St. Louis, USA |
| 18:10-18:30 | Genomic Medicine Sweden – implementing precision medicine in a regionally organized healthcare system Richard Rosenquist Brandell, Karolinska Institutet, Sweden |
| 18:30-19:30 | Welcome reception |
September 21 |
|
| 08:30-17:25 | |
| Session 3: Precision Oncology Chairs: Jonas Bergh, Päivi Östling |
|
| 08:30-08:55 | Impact of genomic sequencing to select treatment for patients with metastatic breast cancer Fabrice André, Gustave Roussy, France |
| 08:55-09:20 | Innovative precision cancer medicine trials Razelle Kurzrock, Michels Rare Cancers Research Laboratories, MCW Cancer Center |
| 09:20-09:45 | Drug repurposing in precision oncology Ulrik Lassen, Department of Oncology, Rigshospitalet, Denmark |
| 09:45-10:10 | Coffee break |
| 10:10-10:35 | Impact of real-world evidence for precision cancer medicine Albrecht Stenzinger, Institute of Pathology, Heidelberg, Germany |
| 10:35-11:05 | Panel discussion |
| 11:05-11:30 | Patient advocacy and precision medicine Bettina Ryll, MPNE, member of the first EU Cancer Mission Board, Sweden |
| 11:30-12:30 | Lunch |
| Session 4: Precision Medicine in Complex Diseases Chairs: Åsa Johansson, Ingrid Skelton Kockum |
|
| 12:30-12:55 | A global perspective on precision medicine for cardiometabolic disease Paul Franks, Novo Nordisk Foundation, Denmark |
| 12:55-13:20 | Future prospects of precision medicine in psychiatric disorders Naomi Wray, University of Oxford, UK |
| 13:20-13:45 | Translational precision medicine in osteoarthritis Eleftheria Zeggini, Helmholtz Zentrum München, Germany |
| 13:45-14:10 | Panel discussion |
| 14:10-14:25 | Break |
| Session 5: Precision Medicine Beyond Genomics Chairs: Olli Kallioniemi, Lucia Cavelier Franco |
|
| 14:25-14:50 | Impact of multi-omic diagnostics in rare diseases Anna Lindstrand, Karolinska Institutet, Sweden |
| 14:50-15:15 | Proteogenomics refines classification and risk-stratification in hematological malignancies Sascha Dietrich, University of Duesseldorf, Germany |
| 15:15-15:40 | Drug Profiling-Based Precision Cancer Medicine Berend Snijder, Institute of Molecular Systems Biology, ETHZ, Switzerland |
| 15:40-16:05 | Panel discussion |
| 16:05-16:35 | Coffee break |
| Precision Medicine in Action – Best Practice Examples Chair: Maria Johansson Soller |
|
| 16:35-17:00 | Precision nutrition in cardiometabolic diseases Jordi Merino, Copenhagen University, Denmark |
| 17:00-17:25 | Building a national genome center – the Danish experience Peter Johansen, Danish National Genome Center, Denmark |
| 17:25-18:50 | Visit to SciLifeLab SciLifeLab is a world-leading Swedish national center for large-scale research and one of the largest molecular biology research laboratories in Europe Please see the program here |
September 22 |
|
| 09:00-13:00 - New starting time! | |
| Session 6: Precision Medicine in Clinical Microbiology Chairs: Jan Albert, Karin Blomqvist |
|
| 09:00-09:25 | Can the Microbiome guide us to better treatment outcomes for patients? Per Falk, Ferring Pharmaceuticals, Switzerland |
| 09:25-09:50 | Advances in precision medicine of infectious diseases Judith Breuer, University College London, UK |
| 09:50-10:10 | Panel discussion |
| Session 7: Innovative Informatics Solutions/Data Sharing Chairs: Valtteri Wirta |
|
| Presentation cancelled Value of comprehensive genomic profiling in cancer Ahmet Zehir, AstraZeneca, USA |
|
| Presentation cancelled Personalized clinical decision-making in cancer based on multi-omics Melanie Börries, University Freiburg, Germany |
|
| 10:10-10:45 | Coffee break |
| 10:45-11:10 | Solving the unsolved with novel bioinformatic solutions Christian Gilissen, Radboud University Medical Center, Netherlands |
| 11:10-11:20 | Panel discussion |
| Session 8: International Perspectives on Precision Medicine Chairs: Anders Edsjö, Janne Lehtiö |
|
| 11:20-11:45 | Implementing precision cancer medicine in Norway Kjetil Tasken, Institute for Cancer Research, Norway |
| 11:45-12:10 | Towards precision medicine: Using the Finnish population structure and nationwide health records to understand the genetic basis of diseases Aarno Palotie, Institute for Molecular Medicine Finland FIMM, Finland |
| 12:10-12:35 | Accelerating genomic medicine in the NHS in England Sue Hill, National Health Service (NHS), England |
| 12:35-12:55 | Panel discussion |
| 12:55-13:00 | Summary and closing remarks Richard Rosenquist Brandell, Karolinska Institutet, Sweden |
| 13:00-14:00 | Lunch |